Barinthus Biotherapeutics logo

Barinthus Biotherapeutics

BRNS | NASDAQ
Chart Builder DCF Calculator
$0.74
-$0.02 (-2.50%)
At close: Sep 8, 2026, 4:00 PM ET
-2.50%

Rating

Updated: Oct 6, 2026
34
+20.5 pts
Fundamentals Weak
Market Sentiment Neutral
Moat None

Key Statistics

Market Data

Market Cap $30.23M
1D Range
0.66 0.76
52W Range
0.51 1.83

Valuation (TTM)

PE -0.72
PB 0.53
EV/EBITDA 0.50

Valuation (NTM)

Forward PE N/A
Forward PEG 0.02
Price Target $3.00
Loading financial charts...

Profile

Barinthus Biotherapeutics PLC is a clinical-stage biopharmaceutical company focused on developing novel immunotherapeutic drug candidates for treating autoimmune and inflammatory diseases. The company...

Sector Healthcare
Industry Biotechnology
Employees 14
IPO Date Apr 30, 2021
Fiscal Year January - December

Latest News

No news articles available yet.

Analyst Summary

# of Analysts
1
Consensus
Buy
Price Target
$3.00
Upside
+305.41%
Buy (1)
Hold (0)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.